Democratic lawmakers marked the third anniversary of the Inflation Reduction Act on 16 August by highlighting its impact on health-care costs, energy investment and job creation. They cited the law’s $35 monthly cap on insulin for Medicare beneficiaries, expanded authority to negotiate prescription-drug prices and premium subsidies that they say have saved households thousands of dollars. Members of Congress also pointed to the legislation’s clean-energy incentives. Representative Glenn Thompson said the measure has already triggered an estimated $208 million in renewable-energy spending in his Pennsylvania district, while colleagues from Texas and Maine credited the act with boosting both fossil-fuel and renewable production nationwide. The Democrats warned that a separate Republican-backed measure, which they referred to as the “Big Ugly Bill,” would roll back many of the law’s provisions and potentially drive up consumer energy bills. They pledged to defend the IRA’s incentives, framing them as central to lowering costs for working families and maintaining U.S. leadership in energy development.
Three years ago, Democrats delivered the Inflation Reduction Act—a historic law that lowered prescription drug costs, reduced energy bills, created millions of good-paying jobs and invested in America’s clean energy future. Its passage was a momentous victory #ForThePeople. https://t.co/D2DdrDTPoM
If the Trump Administration is serious about lowering costs for hardworking Americans, why cut the essential programs aimed at doing just that? I will never stop fighting to lower energy costs for you and your families. https://t.co/0l3XqLrfH7
It’s been three years since the Inflation Reduction Act was signed into law, a historic step forward for our nation. From capping the cost of insulin at $35 for Medicare recipients to lowering prescription drug prices and tackling rising inflation, I’ve been proud to support